Source: Long Island Business News

ABD: Avery Biomedical earns FDA approval for next-gen pacemaker

The device is now being offered to patients using its diaphragm pacemaker.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Linda Towler's photo - CEO of Avery Biomedical Devices Inc

CEO

Linda Towler

CEO Approval Rating

90/100